Review of the first on-body injector (OBI) for the subcutaneous delivery of an oncology drug: isatuximab in multiple myeloma
Expert Opinion on Drug Delivery | April 13, 2026 | Volume: 23 | Issue: 7 | Pages: 1289-1303
10.1080/17425247.2026.2659263
| PMID 41973697